University of South Florida-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:University of South Florida - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013267
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
University of South Florida (USF) is an educational university that offers undergraduate, graduate, specialist and doctoral level degrees. The university offers degrees in various fields including accounting, advertising, Africana studies, American studies, anthropology, applied science, marine science, material science and engineering, and adult education. It also provides courses in behavioral healthcare, biomedical sciences, cell and molecular biology, communication, communication sciences and disorders, entrepreneurship in applied technologies, and environmental engineering, among others. The university also provides distance and online learning, workforce development, noncredit education, pre-college programs and other. It has operations in Tampa, St. Petersburg, Sarasota-Manatee and Lakeland. USF is headquartered in Tampa, Florida, the US.

University of South Florida – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
University of South Florida, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
University of South Florida, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
University of South Florida, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
University of South Florida, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
University of South Florida, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
University of South Florida, Pharmaceuticals & Healthcare, Deal Details 10
Licensing Agreements 10
Agilis Biotherapeutics Enters into Licensing Agreement with University of South Florida 10
Agilis Biotherapeutics Enters into Licensing Agreement with University of South Florida 11
Viteava Pharma Enters Into Licensing Agreement For Intellectual Property Portfolio Of Analogs And Derivatives 12
PsychoGenics Enters Into Licensing Agreement With University of South Florida For APP/PS1 Transgenic Mouse Model 14
Asset Transactions 15
Cellular Biomedicine Acquires Rights to CD40LGVAX Vaccine 15
University of South Florida – Key Competitors 17
University of South Florida – Key Employees 18
University of South Florida – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Research And Development 20
May 09, 2016: USF Professor Studying Relationship Between Causes of Alzheimer’s and CTE, a Disease Found in Athletes with Head Injuries 20
Government and Public Interest 21
Nov 16, 2017: First Ever Effective Intervention Against Dementia Shown in Large Study 21
May 15, 2017: Stem cell transplants may advance ALS treatment by repair of blood-spinal cord barrier 23
Jan 19, 2017: USF Researcher Develops Therapeutic Vaccine to Combat Alzheimer’s Disease and Neurodegenerative Disorders 24
Mar 17, 2016: USF Researchers Receive $9 Million Grant to Develop Strategies to Treat Age-related Hearing Loss 25
Mar 01, 2016: US team tackle immune system in £875,000 Dementia Consortium project 27
Product News 28
Mar 06, 2017: Extended Use of MAO-B Inhibitors Slows Decline in Parkinson’s Disease Patients 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
University of South Florida, Pharmaceuticals & Healthcare, Key Facts 2
University of South Florida, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
University of South Florida, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
University of South Florida, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
University of South Florida, Deals By Therapy Area, 2011 to YTD 2017 8
University of South Florida, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Agilis Biotherapeutics Enters into Licensing Agreement with University of South Florida 10
Agilis Biotherapeutics Enters into Licensing Agreement with University of South Florida 11
Viteava Pharma Enters Into Licensing Agreement For Intellectual Property Portfolio Of Analogs And Derivatives 12
PsychoGenics Enters Into Licensing Agreement With University of South Florida For APP/PS1 Transgenic Mouse Model 14
Cellular Biomedicine Acquires Rights to CD40LGVAX Vaccine 15
University of South Florida, Key Competitors 17
University of South Florida, Key Employees 18
University of South Florida, Subsidiaries 19

★海外企業調査レポート[University of South Florida-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • 3M India Limited (3MINDIA):企業の財務・戦略的SWOT分析
    3M India Limited (3MINDIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Commercial Bank of Dubai PSC:企業の戦略・SWOT・財務情報
    Commercial Bank of Dubai PSC - Strategy, SWOT and Corporate Finance Report Summary Commercial Bank of Dubai PSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • MorphoSys AG:企業のM&A・事業提携・投資動向
    MorphoSys AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's MorphoSys AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Georgetown University:製薬・医療:M&Aディール及び事業提携情報
    Summary Georgetown University (GU) is an academic and research institute that offers educational services. The university provides undergraduate and graduate degree programs in the fields of law, medical, medical residencies, business administration and public policy degrees, post-doctoral positions …
  • Cosan S.A. Industria e Comercio (CSAN3)-エネルギー分野:企業M&A・提携分析
    Summary Cosan S.A. Industria e Comercio (Cosan), a subsidiary of Cosan Limited, is an integrated bioenergy company. It invests in diversified industries, including agribusiness, fuel and natural gas distribution, and lubricants. The company distributes lubricants, fuel oil, and piped natural gas; an …
  • Mondi Limited:企業の戦略・SWOT・財務情報
    Mondi Limited - Strategy, SWOT and Corporate Finance Report Summary Mondi Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Cutera Inc (CUTR):企業の財務・戦略的SWOT分析
    Cutera Inc (CUTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Theraclion SA (ALTHE):企業の財務・戦略的SWOT分析
    Summary Theraclion SA (Theraclion) is a medical device company that designs, markets, and develops high-intensity focused therapeutic ultrasound devices and equipment; and offers technical support services. The company offers echotherapy solution that combines HIFU therapy with ultrasound as a syste …
  • Novita Healthcare Ltd (NHL)-製薬・医療分野:企業M&A・提携分析
    Summary Novita Healthcare Ltd (Novita Healthcare), formerly Avexa Ltd is a medical technology company that focuses on the measurement and treatment of attention difficulties in early childhood. The company operates through its subsidiary The Tali technology, which is developing a tablet based softwa …
  • Mannai Corporation QSC:企業のM&A・事業提携・投資動向
    Mannai Corporation QSC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mannai Corporation QSC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Diamyd Medical AB (DMYD B):製薬・医療:M&Aディール及び事業提携情報
    Summary Diamyd Medical AB (Diamyd), formerly Diamyd Therapeutics AB is a drug development company that offers diabetes vaccine. The company's diabetes products include Diamyd, an antigen-based immunotherapy for the treatment of autoimmune diabetes. Its pipeline products include GAD, GABA, and other …
  • Duke Energy Corp (DUK):企業の財務・戦略的SWOT分析
    Duke Energy Corp (DUK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • InSightec Ltd:企業の製品パイプライン分析2018
    Summary Insightec Ltd (InSightec), a subsidiary of Elbit Imaging Ltd, is a medical device company that develops and markets magnetic resonance imaging ultrasound based medical devices. The company offers products through divisions such as neurosurgery, urology, oncology and womens’ health. Its servi …
  • Sigma-Tau HealthScience USA, Inc:企業の戦略・SWOT・財務情報
    Sigma-Tau HealthScience USA, Inc - Strategy, SWOT and Corporate Finance Report Summary Sigma-Tau HealthScience USA, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • equensWorldline SE:企業の戦略・SWOT・財務情報
    equensWorldline SE - Strategy, SWOT and Corporate Finance Report Summary equensWorldline SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Hunter Douglas NV (HDG):企業の財務・戦略的SWOT分析
    Hunter Douglas NV (HDG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Arcbest Corp.:企業の戦略・SWOT・財務分析
    Arcbest Corp. - Strategy, SWOT and Corporate Finance Report Summary Arcbest Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • 3D Systems Corporation:企業の戦略・SWOT・財務情報
    3D Systems Corporation - Strategy, SWOT and Corporate Finance Report Summary 3D Systems Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Blueprint Medicines Corp (BPMC):企業の財務・戦略的SWOT分析
    Summary Blueprint Medicines Corp (Blueprint Medicines), formerly Hoyle Pharmaceuticals Inc, discovers and develops precision therapies for the treatment of cancers and rare diseases. The company offers AYVAKIT (avapritinib) medicine to treat gastrointestinal stromal tumor (GIST); and GAVRETO (pralse …
  • Flextronics International Ltd.:戦略・SWOT・企業財務分析
    Flextronics International Ltd. - Strategy, SWOT and Corporate Finance Report Summary Flextronics International Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆